IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
A Phase 3 Study of Tanezumab for Chronic Low Back Pain (TANGO)
This study is currently recruiting participants.
Verified July 2017 by Pfizer
Sponsor:
Pfizer
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT02528253
First received: August 11, 2015
Last updated: July 7, 2017
Last verified: July 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 16, 2019 |
| Estimated Primary Completion Date: | October 17, 2017 (Final data collection date for primary outcome measure) |